These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4600261)

  • 1. [Letter: Hyperphosphatemia and hypocalcemia following treatment of reticulosarcoma].
    Durand M; Hoerni-Simon G; Hoerni B
    Nouv Presse Med; 1974 Mar; 3(11):677. PubMed ID: 4600261
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Hyperphosphatemia and hypocalcemia in neoplastic disorders.
    N Engl J Med; 1974 Apr; 290(15):857-9. PubMed ID: 4361763
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia.
    Zusman J; Brown DM; Nesbit ME
    N Engl J Med; 1973 Dec; 289(25):1335-40. PubMed ID: 4518614
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperphosphatemia and hypocalcemia in Burkitt lymophoma. Complications of chemotherapy.
    Brereton HD; Anderson T; Johnson RE; Schein PS
    Arch Intern Med; 1975 Feb; 135(2):307-9. PubMed ID: 1147733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic and renal changes in lymphoproliferative syndromes of childhood].
    Madero López L; Muñoz Villa A; Gallego Cobos N; Onsurbe Ramírez I
    An Esp Pediatr; 1985 Feb; 22(2):107-12. PubMed ID: 3857017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management.
    Sutters M; Gaboury CL; Bennett WM
    J Am Soc Nephrol; 1996 Oct; 7(10):2056-61. PubMed ID: 8915965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complex treatment of reticulosarcoma and lymphosarcoma patients].
    Kruglova GV; Lorie IuI; Mansurov AN
    Klin Med (Mosk); 1974 Apr; 52(4):42-9. PubMed ID: 4617809
    [No Abstract]   [Full Text] [Related]  

  • 8. Corpuscles of Stannius-extract-induced rapid but transient hypocalcemia and hyperphosphatemia in stingray, Dasyatis akajei.
    Srivastav AK; Srivastav SK; Sasayama Y; Suzuki N
    Gen Comp Endocrinol; 1996 Oct; 104(1):37-40. PubMed ID: 8921353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
    van Agthoven M; Wittebol S; Budel LM; Uyl-de Groot CA; Kramer MH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):88-93. PubMed ID: 14753131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with cyclophosphamide, vincristine, procarbazine and prednisone in Hodgkin's disease and reticulum cell sarcoma.
    Isola LM; Cremerius de Sica SM; Palau M; Pereyra MA; Alzugaray AE
    Medicina (B Aires); 1971; 31(2):93-7. PubMed ID: 4935790
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
    Cheson BD
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):4-6. PubMed ID: 18998258
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of reticulosarcoma with vincristine].
    Bevilacqua L; Conte G; Fiorentino M; Grigoletto E
    Cancro; 1968; 21():Suppl 6:98+. PubMed ID: 4906147
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypoglycemia during lymphosarcoma and reticulosarcoma].
    Buffet C; Bonnefond A; Mignon M; Hakim J
    Nouv Presse Med; 1974 Jan; 3(4):181-4. PubMed ID: 4593766
    [No Abstract]   [Full Text] [Related]  

  • 14. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extreme hyperphosphatemia with hypocalcemia within the scope of cell lysis syndrome in a child with T-ALL].
    Kabisch H; Niggemann B; Winkler K
    Onkologie; 1989 Apr; 12(2):64-8. PubMed ID: 2660048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New concepts in treatment approaches and prognostic factors in aggressive NHL.
    Shipp M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
    Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe hyperphosphatemia and hypocalcemia following sodium phosphate bowel preparation: a forgotten menace.
    Ma KK; Ng CS; Mui LM; Chan KC; Ng EK; Chung SC
    Endoscopy; 2003 Aug; 35(8):717. PubMed ID: 12929079
    [No Abstract]   [Full Text] [Related]  

  • 20. The limits of limited stage lymphoma.
    Miller TP
    J Clin Oncol; 2004 Aug; 22(15):2982-4. PubMed ID: 15210737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.